Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; ...
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of ...
Pengerang Biorefinery Sdn. Bhd. launched a project to build a bio-processing plant in Pengerang (Malaysia). This is reported in a press release from Eni. Pengerang Biorefinery is a joint venture ...
An implantable bioartificial kidney being developed by The Kidney Project – a nationwide collaboration led by Bangladeshi American Professor Shuvo Roy of U.C. San Francisco and Dr. William Fissell of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback